Refractory Acute Leukemia of Ambiguous Lineage

specific

An acute leukemia of ambiguous lineage that is resistant to treatment.

32

Centers

33

Active Trials

Cancer Funding

Top Centers for Refractory Acute Leukemia of Ambiguous Lineage(32)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
73.4
2
NCI Comprehensive
Active Research Program
50.9
3
NCI Comprehensive
Active Research Program
50.9
4
NCI Comprehensive
Active Research Program
50.9
5
NCI Comprehensive
Active Research Program
50.9
6
NCI Comprehensive
Active Research Program
50.9
7
NCI Comprehensive
Active Research Program
50.9
8
NCI Comprehensive
Active Research Program
50.9
9
NCI Comprehensive
Active Research Program
50.9
10
NCI Comprehensive
Active Research Program
50.9
1150.9
12
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
50.9
13
NCI Comprehensive
Active Research Program
50.9
14
NCI Comprehensive
Active Research Program
50.9
15
NCI Clinical
Active Research Program
50.9
16
NCI Comprehensive
Active Research Program
50.9
17
NCI Comprehensive
Active Research Program
50.9
18
NCI Clinical
Active Research Program
50.9
19
NCI Comprehensive
Active Research Program
50.9
20
NCI Clinical
Active Research Program
50.9
21
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
50.9
22
Active Research Program
50.9
23
NCI Comprehensive
Active Research Program
50.9
24
Active Research Program
50.9
25
Active Research Program
50.9
2650.9
27
Active Research Program
50.9
28
Active Research Program
50.9
29
Active Research Program
50.9
30
Active Research Program
50.9
31
Active Research Program
50.9
32
BC CancerVancouver, BC
Active Research Program
50.9

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →